PhD student Eilam Yeini and Prof. Ronit Satchi-Fainaro at Tel Aviv University. Photo courtesy of TAUGlioblastoma is a particularly aggressive form of brain cancer, accounting for half of all primary brain cancers. It has a 40 percent survival rate after a year and just 5% after five years, even after surgery, radiation and chemotherapy.
Researchers at Tel Aviv University have discovered a potential treatment, tested on mice and 3D lab models so far.
